Roxburgh Patricia, Glasspool Rosalind
Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK,
Curr Oncol Rep. 2014 Dec;16(12):413. doi: 10.1007/s11912-014-0413-1.
Squamous ovarian cancer (SOC) represents a (very) rare subtype of ovarian cancer. The lack of evidence on which to base management presents significant challenges. The small number of patients prohibits randomised studies to establish level 1 evidence, and no non-randomised studies or prospective series have been reported. Here, we present a review of the available literature on squamous ovarian cancer and explore some lessons learnt from squamous cancers originating from other primary sites to see if these can be applied to SOC.
鳞状上皮性卵巢癌(SOC)是卵巢癌中一种(非常)罕见的亚型。缺乏用于指导治疗的证据带来了重大挑战。患者数量较少使得难以开展随机研究以确立一级证据,且尚无非随机研究或前瞻性系列报道。在此,我们对鳞状上皮性卵巢癌的现有文献进行综述,并探讨从源自其他原发部位的鳞状细胞癌中汲取的一些经验教训,看是否可应用于SOC。